0001628280-24-028072.txt : 20240613 0001628280-24-028072.hdr.sgml : 20240613 20240613162602 ACCESSION NUMBER: 0001628280-24-028072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240612 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schall Thomas J. CENTRAL INDEX KEY: 0001423084 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40675 FILM NUMBER: 241041603 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immuneering Corp CENTRAL INDEX KEY: 0001790340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-500-8080 MAIL ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wk-form4_1718310353.xml FORM 4 X0508 4 2024-06-12 0 0001790340 Immuneering Corp IMRX 0001423084 Schall Thomas J. C/O IMMUNEERING CORPORATION 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 1 0 0 0 0 Stock Option 1.54 2024-06-12 4 A 0 8588 0 A 2034-06-12 Class A Common Stock 8588 8588 D The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first. /s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall 2024-06-13